Wang et al. showed that p38gamma-MAPK promotes pancreatic cancer by activating PFKFB3 and GLUT2 through the KRAS oncogene signaling and aerobic glycolysis (Wang et al., 2020). This evidence concerns the gene MAPK12 and pancreatic neoplasm.